ELLINGTON MANAGEMENT GROUP LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2018$179,000
-32.7%
18,900
-25.3%
0.05%
+152.6%
Q1 2018$266,000
-52.7%
25,300
-68.0%
0.02%
-76.5%
Q2 2017$562,000
+31.3%
79,100
+165.9%
0.08%
-22.9%
Q2 2015$428,000
-42.1%
29,743
-64.0%
0.10%
-31.4%
Q1 2015$739,000
+90.5%
82,600
+217.7%
0.15%
+34.2%
Q1 2014$388,00026,0000.11%
Other shareholders
IMMUNOGEN INC shareholders Q2 2017
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders